Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meeting, 37334 [2014-15299]
Download as PDF
<![CDATA[
emcdonald on DSK67QTVN1PROD with NOTICES
37334
Federal Register / Vol. 79, No. 126 / Tuesday, July 1, 2014 / Notices
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–615–7401, wup4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; HIV/AIDS
Innovative Research Applications.
Date: July 23–24, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Continuous Submissions:
Respiratory Diseases.
Date: July 24–25, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 435–
1195, Chengy5@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Urology and Nephrology.
Date: July 24, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Patricia Greenwel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1169, greenwep@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: June 23, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Announcement of Workshops for the
Development of New Antibacterial
Products
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, June 17, 2014,
08:30 a.m. to June 17, 2014, 12:00 p.m.,
Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD,
20814 which was published in the
Federal Register on May 19, 2014, 79
FR 28740.
The meeting notice is amended to
change the date of the ZHD1 Special
Emphasis Panel meeting from June 17,
2014 to July 8, 2014. The meeting will
now be a telephone conference call and
will be closed to the public.
Dated: June 25, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15299 Filed 6–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Cancellation of Meeting
Notice is hereby given of the
cancellation of the National Children’s
Study Advisory Committee, July 11,
2014, 9:00 a.m. to July 11, 2014, 4:45
p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on June 16, 2014, 79 FR 34332.
The meeting of the National
Children’s Study Advisory Committee is
cancelled for July 11, 2014, 9:00 a.m. to
4:45 p.m.
Dated: June 24, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15296 Filed 6–30–14; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2014–15295 Filed 6–30–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
19:00 Jun 30, 2014
Jkt 232001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
National Institutes of Health,
Department of Health and Human
Services.
ACTION: Notice of Public Workshop.
AGENCY:
The National Institutes of
Health (NIH), Office of the Director,
Office of Science Policy, and the Food
and Drug Administration (FDA), Office
of the Commissioner, are announcing a
public workshop titled ‘‘The
Development of New Antibacterial
Products: Charting a Course for the
Future.’’ The workshop is being held to:
(1) Examine key issues and challenges
related to antibacterial product
development, (2) discuss regulatory
pathways for bringing new antibacterial
drugs to market, (3) identify strategies
for promoting clinical trials for
antibacterial drugs, and (4) encourage
partnerships to accelerate the
development of new antibacterial drugs.
The workshop is open to the public and
is free of charge.
DATES: The workshop will be held on
July 30 and 31, 2014, from 8:00 a.m. to
5:15 p.m. and from 8:00 a.m. to 1:00
p.m., respectively. The registration
deadline is July 14, 2014.
ADDRESSES: The workshop will be held
at the Bethesda North Marriott Hotel
and Conference Center, 5701 Marinelli
Road, North Bethesda, Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Kelly Fennington, NIH, Office of
Science Policy, 6705 Rockledge Drive,
Room 750, Bethesda, MD 20892–7985;
301–496–9838; email: FenningK@
mail.nih.gov.
SUMMARY:
Specific
issues to be discussed at this workshop
include: (1) Priorities and strategic
approaches to conducting clinical trials
for antibacterial drugs; (2) regulatory
pathways, including streamlined
programs for the development of
antibacterial drugs for patients with
limited or no treatment options; (3)
clinical trial design, including the
development of a common clinical
protocol, use of common control groups,
statistical design, data sharing across
trial, clinical trial endpoints, and
lessons learned from other therapeutic
areas; and (4) the role of public-private
partnerships in advancing the
development of antibacterial drugs.
Participants will include individuals
SUPPLEMENTARY INFORMATION:
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 79, Number 126 (Tuesday, July 1, 2014)]
[Notices]
[Page 37334]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15299]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Child Health and Human Development Special Emphasis Panel,
June 17, 2014, 08:30 a.m. to June 17, 2014, 12:00 p.m., Residence Inn
Bethesda, 7335 Wisconsin Avenue, Bethesda, MD, 20814 which was
published in the Federal Register on May 19, 2014, 79 FR 28740.
The meeting notice is amended to change the date of the ZHD1
Special Emphasis Panel meeting from June 17, 2014 to July 8, 2014. The
meeting will now be a telephone conference call and will be closed to
the public.
Dated: June 25, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-15299 Filed 6-30-14; 8:45 am]
BILLING CODE 4140-01-P
